CEST MRI of glucosamine uptake in brain tumor-bearing mice
Researchers have successfully used glucosamine-based CEST MRI to detect brain tumors in a mouse model. This non-radioactive imaging technique provides a biocompatible alternative to traditional cancer detection methods like FDG-PET.
Why it matters
This development could lead to safer, more accessible diagnostic imaging for brain cancer patients by avoiding radioactive tracers.
Scientific Reports ( 2026 ) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in